At Cytotheryx, we understand that life-saving discovery in liver disease research and medicine requires a multi-faceted approach. The key to enabling this innovation is a reliable foundation. We understand this need and the opportunity to support numerous areas working to advance human health—this is our sole focus.
Our team has developed a revolutionary bioincubator capable of propagating high-quality, consistent primary human hepatocytes, or liver cells. With this technology, the liver research community will gain extended access to the quantity and quality of human liver cells required to advance disease-specific research. Our bioincubator also provides the tools needed to develop new applications for drug delivery, cell and gene therapies, liver assist devices, and even allotransplantation.